The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study

Hepatology

Volumn 34, Issue 6, 2001, Pages 1193-1199

  Di Martino, Vincent ^a,c   Rufat, Pierre ^a   Boyer, Nathalie ^a   Renard, Philippe ^a   Degos, Françoise ^a   Martinot Peignoux, Michèle ^a   Matheron, Sophie ^b   Le Moing, Vincent ^b   Vachon, François ^b   Degott, Claude ^a   Valla, Dominique ^a   Marcellin, Patrick ^a  

^a BEAUJON HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; INTERFERON; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; COMORBIDITY; DRUG ABUSE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 0035179821     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.29201     Document Type: Article

References (43)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
3. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
4. The progression of HCV-associated liver disease in a cohort of haemophilic patients
5. Natural history of hepatitis C virus infection in multitransfused haemophiliacs: Effects of coinfection with human immunodeficiency virus
6. Hepatitis C virus infection in patients infected with the immunodeficiency virus
7. Influence of HIV infection on chronic hepatitis C on intravenous drug addicts
8. Liver fibrosis progression in patients with hepatitis C, with and without HIV infection
9. Hepatitis C in HIV-infected patients with and without AIDS: Prevalence and relationship to patient survival
10. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS
11. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users
12. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?
13. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV cohort study
14. A longitudinal analysis of hepatitis C virus replication following liver transplantation
15. Influence of the genotypes on the severity of recurrent liver disease after liver transplantation
16. Natural history of liver fibrosis progression in patients with chronic hepatitis C
17. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6, 664 patients
18. Tutorial in biostatitics. Multivariate prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
19. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
20. Irish Hepatology Research Group clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
21. 45-Year follow-up of hepatitis C virus infection in healthy young adults
22. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune restoration disease?
23. Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy
24. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
25. Indinavir-associated hepatitis in patients with advanced HIV infection
26. Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir
27. Severe hepatitis in three AIDS patients treated with indinavir
28. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
29. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency
30. Long-term outcome of chronic hepatitis C infection after liver transplantation
31. Human immunodeficiency virus infection of the liver
32. Changes in the functions of the endothelial cells of the human liver sinusoid after human immunodeficiency virus (HIV) infection in vitro
33. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users
34. Evidence that both HIV and HIV-induced immuno-deficiency enhance HCV replication among HCV seroconverters
35. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs
36. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection
37. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury
38. Molecular analysis of mixed infection with hepatitis C virus and human immunodeficiency virus in a patient infected simultaneously
39. Impact of medical recommendations on alcohol consumption in HCV positive patients
40. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
41. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C
42. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view
43. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia